Skip to main content
Premium Trial:

Request an Annual Quote

Italian Organizations Ink Cancer Biomarker Deals with UK Firms

NEW YORK (GenomeWeb) – TTFactor — the technology transfer firm of the European Institute of Oncology and the FIRC Institute of Molecular Oncology — investment firm BioVitas Capital, and the University of Milan today announced two deals to develop genomic biomarkers for lung, breast, and ovarian cancers.

In one agreement, the parties will collaborate with BioVitas-funded startup Gensignia, based in London, to develop microRNA-based signatures for detecting lung, breast, ovarian, and other cancers. The European Institute of Oncology, FIRC, and the University of Milan performed the original research, which is now being validated on a large cohort of patients in a clinical study sponsored by the European Institute of Oncology.

In a second deal, the parties are working with UK firm Tiziana Life Sciences, also a BioVitas-funded firm, to validate a gene signature of breast cancer stem cells. The agreement is aimed at defining better treatment options by genetically profiling patients. Tiziana discovers and develops molecules associated with cancer, with a particular emphasis on metastatic cancers.

Terms of the agreements were not disclosed.

The Scan

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.